January 29, 2019 | Michael Easterling
In January 1979, the National Academy of Sciences published a paper about an innovative discovery at City of Hope that would forever change how diabetes is treated. Arthur Riggs, Ph.D., and Keiichi Itakura, Ph.D., revolutionized diabetes treatment when they made a novel gene, one that coded for human insulin.
City of Hope doctor co-edits annual report highlighting cancer breakthroughs
January 31, 2019 | Michael Easterling
Sumanta K. Pal, M.D., was selected to serve as one of three editors of this year’s Clinical Cancer Advances, an annual report on the progress against cancer distributed by the American Society of Clinical Oncology.
Clinical research nurses: ‘Shepherds’ of the CAR T program
January 9, 2019 | Abe Rosenberg
What's it like to work at the center of a true medical and scientific revolution? It's emotional, often overwhelming. But it’s also a place to witness miracles. Such is the life of the clinical research nurses who staff City of Hope's CAR T cell program.
City of Hope investigators present breakthrough research at 60th American Society of Hematology meeting
December 5, 2018 | Letisia Marquez
Physicians and researchers at the 2018 American Society of Hematology conference presented clinical trials for new leukemia and lymphoma treatments, laying the groundwork for innovative therapeutic approaches aimed at improving treatment options and quality of life for patients.
Groundbreaking new CAR T cell trial opens for patients with breast cancer that has spread to the brain
October 30, 2018 | Letisia Marquez
A new City of Hope chimeric antigen receptor (CAR) T cell trial – the first to focus on HER2-postive breast cancer patients with brain metastases – is now enrolling potential participants.
Parker Institute for Cancer Immunotherapy Welcomes Stephen J. Forman, M.D.
September 27, 2018 | Letisia Marquez
City of Hope’s Stephen J. Forman, M.D., is now an official member of the Parker Institute for Cancer Immunotherapy.
City of Hope's Stephen J. Forman Joins Parker Institute for Cancer Immunotherapy
July 16, 2018 | Letisia Marquez
City of Hope’s CAR T research and treatment team is now an official member of the Parker Institute for Cancer Immunotherapy.
Stephen Forman, M.D., Inducted into AAP
May 30, 2018 | Michael Easterling
Stephen J. Forman, M.D., the Francis & Kathleen McNamara Distinguished Chair in Hematology and Hematopoietic Cell Transplantation, has been inducted as a member of the Association of American Physicians.
Six Lessons from Behind the Scenes at City of Hope’s CAR T Cell Program
April 2, 2018 | Wayne Lewis
Often unrecognized are the countless folks who work in the spaces between the lab and the clinic — people responsible for doing everything from manufacturing CAR T cells to gaining federal approval for new trials.